作者：
Stevens,R.J. [1]
;
Ali,R. [2]
;
Bankhead,C.R. [3]
;
Bethel,M.A. [4]
;
Cairns,B.J. [5]
;
Camisasca,R.P. [6]
;
Crowe,F.L. [7]
;
Farmer,A.J. [8]
;
Harrison,S. [9]
;
Hirst,J.A. ;
Home,P. ;
Kahn,S.E. ;
McLellan,J.H. ;
Perera,R. ;
Plüddemann,A. ;
Ramachandran,A. ;
Roberts,N.W. ;
Rose,P.W. ;
Schweizer,A. ;
Viberti,G. ;
Holman,R.R.
作者单位：
Novartis Pharma, Basel, Switzerland
[1]
Cancer Epidemiology Unit, University of Oxford, Oxford, United Kingdom
[2]
India Diabetes Research Foundation, Dr A. Ramachandran's Diabetes Hospitals, Egmore, Chennai, India
[3]
ICM-Diabetes, Medical School, Newcastle University, Newcastle upon Tyne, United Kingdom
[4]
Diabetes Trials Unit, Oxford Centre for Diabetes Endocrinology and Metabolism, University of Oxford
[5]
Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, Veterans Affairs Puget
[6]
Unit for Metabolic Medicine, School of Medicine, King's College London, London, United Kingdom
[7]
Department of Primary Care Health Sciences, University of Oxford, Woodstock Road, Oxford OX2 6GG
[8]
TGRD Europe, Takeda Pharmaceutical Company, London, United Kingdom
[9]
发布时间
2013-11-20
换一批
